February 14, 2025 - 07:30

In a significant shift in policy, employees of the Centers for Disease Control and Prevention (CDC) are now required to seek approval from the executive branch before publishing any research findings. This new directive imposes strict limitations on the ability of CDC scientists to share their work with the public and the scientific community.
Under these guidelines, CDC staff must also withdraw their names from any external papers that are awaiting publication. This move has raised concerns among public health experts and researchers about the potential impact on scientific transparency and the dissemination of critical health information. Critics argue that such restrictions could hinder the progress of vital research and limit the agency's ability to respond effectively to public health challenges.
As the CDC navigates these changes, the implications for scientific collaboration and the agency's role in public health communication remain to be seen. The scientific community is closely watching how these policies will affect ongoing and future research initiatives.
July 30, 2026 - 02:45
Texas health issues alert after 4 Montgomery County residents infected with measlesTexas health authorities have issued a public health alert after four members of an unvaccinated family in Montgomery County tested positive for measles. The cases, all linked to a single household...
July 29, 2026 - 08:53
Local nonprofits call for changes at Bexar County jail over custody deaths, healthcare concernsHouston, Dallas, and San Antonio operate the three largest county jail systems in Texas. But so far this year, Bexar County has recorded the highest number of deaths among inmates in custody,...
July 28, 2026 - 17:12
Private Equity Firm Unloads Mental Health Chain Into Muni MarketA private equity firm based in Connecticut is moving to offload a network of mental health clinics and sober-living facilities, using a financing structure that taps into the municipal bond market....
July 28, 2026 - 03:52
Peptides are the latest wellness trend – but do they work?A US drug advisory committee has recently given a nod of approval to several experimental peptides, signaling a potential shift in how these compounds are viewed by regulators. Yet despite the...